ACE2 and COVID-19: a deficit of angiotensin (Ang) 1–7 (a peptide that binds the receptor Mas, produced by ACE2 following its binding to angiotensin II and its consequent cleavage) leads to the pro-inflammatory polarization of macrophages, resulting in the dysregulation of the inflammatory response, which has been typically observed in COVID-19.